sellWeak10b5-1 plan
Peter Virsik sold $4,823 of EPIX
Chief Operating Officer at ESSA Pharma Inc.. 694 shares at an average of $6.95, traded May 6, 2024, filed May 6, 2024.
Warning score
0Value
$4,823
694 shares
Holdings after
11,246
-6% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +20RoleCOO
- 0Trade size$5k at market
- 0Share of holdings soldSold 5.8% of holdings
- 0ClusterNo other insider selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950172-24-000249, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 6, 2024 | SOpen-market sale Common Shares10b5-1 | -694 | $6.95 | $4,823 | 11,246 | May 6, 2024 |
Related signals
Other insiders at ESSA Pharma Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 12Weak | EPIXsell ESSA Pharma Inc. | Bvf Partners L P/il owner | $293 156 shares | -0% | |
| 57Moderate | EPIXsell ESSA Pharma Inc. | Biotech Growth N V owner | $12M 7,879,583 shares | -100% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $4,185 694 shares | -8% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $4,164 694 shares | -8% | |
| 5Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $13k 2,082 shares | -19% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $5,510 694 shares | -5% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $6,232 694 shares | -5% | |
| 26Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $749k 72,782 shares | -85% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $11k 1,194 shares | -9% | |
| 0Weak | ESSA Pharma Inc. | Peter Virsik Chief Operating Officer | $17k 1,718 shares | -11% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.